LGALS3 and cardiac arrest: Regarding strengths, this is the first study to examine galectin-3 as a prognostic biomarker for long-term post-arrest mortality and cerebral dysfunction simultaneously, thus introducing a novel application for this molecule and highlighting its potential role in a multimarker approach for risk stratifying cardiac arrest survivors.